BACKGROUND: This study explores whether externalizing religious and spiritual beliefs is associated with advanced-stage colon cancer at initial oncology presentation and whether this association is stronger for blacks than for whites. METHODS: Patients who had newly diagnosed, invasive colon cancer were recruited at 9 sites in the Chicago metropolitan area. Eligible patients were nonHispanic white or black, ages 30 to 79 years, and diagnosed with a primary invasive colon cancer. Patients were interviewed on prior screening and diagnosis. Social and attitudinal constructs were measured, including the God Locus of Health Control (GLHC) and Religious Problem Solving. The final response rate was 52% and included 407 patients. RESULTS: The median age was 59 years (range, 30-79 years), and 51% of participants were black. Cancer stage was available for 389 (96%) patients and was divided between late stage (stages III-IV; 60%) and early stage (stages I-II; 40%). Multivariate analysis indicated that patients in the highest tertile of scores on the GLHC were more likely have an advanced stage of disease at presentation (odds ratio, 2.14; 95% confidence interval, 1.00-4.59; P 5.05) compared with those in the lowest tertile. No significant interaction was identified between race and GLHC scores for stage at presentation (P 5.78). CONCLUSIONS: In a large sample of black and white individuals across diverse health care systems, higher scores on the GLHC predicted late disease stage at presentation. Although blacks had significantly higher GLHC scores, race was not associated with stage at presentation, nor was the association between GLHC and stage limited to blacks. Further work is needed to better understand this association and to develop interventions to better connect the religious and health care spheres.
INTRODUCTION
Research consistently demonstrates that age-adjusted mortality rates for colon cancer are higher among blacks than among whites in the United States. 1, 2 Although no single factor completely explains these differences in mortality, advanced stage at cancer diagnosis appears to explain as much as 60%. 3 Although the reasons for advanced stage of cancer by race are certainly multifactorial, an important but understudied area pertains to black and white differences in religious and spiritual beliefs and attitudes, which may influence the decision to get screened and be treated if diagnosed with cancer.
Religion and spirituality (R/S) are important resources that individuals with cancer, especially those from racial and ethnic minority backgrounds, often use to help them cope with illness. 4 Research suggests that R/S generally have a positive association with greater emotional well being and better quality of life for patients with cancer. 5, 6 However, important exceptions have been observed, including negative associations between R/S struggle (eg, feeling abandoned by God) and poorer emotional well being or life satisfaction. 7 Other studies indicate that some dimensions of R/S, such as frequency of worship attendance, are associated with greater adherence to recommended cancer screening. 8, 9 However, some investigators report contrary findings about the relation between R/S and cancer-related health behavior. 10, 11 In the current study, we focused on 2 of the many dimensions of R/S: religious problem solving and beliefs about God's control, which have been described as a type of externalizing religious belief, such as believing in miraculous healing and deferring responsibility for health outcomes from the self onto God. 10 Researchers conceptualize this belief that God is in control of our health as God locus of health control and an instrument (the God Locus of Health Control [GLHC]) scale was developed to measure it. 12 R/S problem solving, a type of R/S coping, refers to R/S-oriented or informed actions that individuals take in the face of problems or stressors. 13 Pargament et al have described 3 types of religious problem solving 14 : Collaborative religious problem solving is characterized by an individual working together with God to address their problems, deferring religious problem solving is characterized by an individual waiting for God to make things better rather than actively addressing problems themselves, 14 and self-directing problem solving is characterized by an individual seeking to solve their problems without God's help. Because this study focused on externalizing R/S beliefs and problem solving, selfdirecting problem solving was not included. Like other forms of more active coping, collaborative religious problem solving may be associated with better outcomes in many situations.
The first objective of the current study was to examine whether high levels of GLHC and deferring religious problem solving were associated with later disease stage at presentation among a sample of non-Hispanic white and black patients with newly diagnosed colon cancer. Other research suggests that both GLHC and deferring religious problem solving may be more prevalent among blacks than whites 15, 16 ; therefore, the second objective of the project was to examine whether there were black-white racial differences in the association between measures of R/S and late disease stage at presentation.
MATERIALS AND METHODS

Study Population
Patients with newly diagnosed colon cancer were recruited from 9 Chicago-area public and private (academic and nonacademic) cancer care clinics. Institutional review board approvals were obtained at all institutions. Eligibility included self-identified, non-Hispanic whites or blacks between ages 30 and 79 years residing in Cook, DuPage, Lake, or Will Counties in Illinois and Lake County in Indiana who were and diagnosed between January 1, 2010 and December 31, 2013. Participating institutions identified and contacted patients by mail for recruitment by the University of Illinois at Chicago Survey Research Laboratory. Patients consented to a 90-minute interview, and colon cancer diagnosis information was abstracted from their medical records. The participation rate was 52%. Poststratification response weights were created to account for differences between responders and nonresponders. Weights were created to match the full distribution of eligible patients identified at the 9 facilities on race, sex, age, and recruitment facility.
Variables
Demographic and clinical variables
Demographic and socioeconomic variables obtained from self-reported patient interview data included race/ethnicity, age at diagnosis, marital status, sex, employment status, education level, and annual household income. Age at diagnosis was categorized as ages <50, 50 to 59, 60 to 69, and 70 o 79 years. Race was categorized as non-Hispanic white or black. The 9 recruitment sites were categorized as public, private nonacademic, and academic. Level of educational achievement was reported in years and categorized as less than, equal to, or exceeding a high school degree. Annual household income was categorized as <$20,000, $20,000 to $50,000, or >$50,000. Health insurance status at the time of diagnosis was defined as none or public versus private insurance, including supplemental insurance among Medicare recipients. Relationship status was categorized as married/cohabitating or not married/cohabitating. Comorbidities were self-reported using the Katz Comorbidity Scale 17 and were categorized as none, 1, or 2.
Cancer stage
Cancer stage at definitive diagnosis was determined from chart abstraction of pathology reports, staging reports, and surgical reports. Stage was categorized as late (stage III, IV) or early (stage I or II). Cancer stage information was available for 96% of the sample. We chose to dichotomize stage, because we believed that the early and late stages were clinically relevant separations that would more likely reflect a delay in seeking appropriate screening or diagnostic care.
R/S variables
Religious problem solving. We used the deferring and collaborative Religious Problem-Solving (RPS) subscales (the RPS-D and RPS-C, respectively) from the Pargament Religious Problem Solving scale (6 items each; potential score, 6-30).
14 Deferring religious problem solving is an external problem-solving style in which an individual waits for solutions from God. Collaborative religious problem solving is an internalizing problem-solving coping style in which an individual and God work together toward a solution for a problem. Scores from each scale were summed and evaluated on a continuous scale and then divided into tertiles based on the sample distribution. Tertiles in all places noted in the analysis were used to facilitate ease of interpretation for the reader and do not impact overall levels of significance. Cronbach a values for the RPS-D and RPS-C were .96 and .97, respectively, for the study sample (for R/S survey questions, see Supporting Table 1 ).
The GLHC scale. The GLHC scale (6 items; potential score, 6-30, higher scores are correlated with greater GLHC) assesses the belief that God is the locus of control in a patient's disease. 12 An example of an item from the measure is, "God is in control of my health." A total scale score was calculated for the GLHC by adding the scores for each item (ie, from 1 [strongly disagree] to 5 [strongly agree]). Scores on the GLHC were divided into tertiles based on the sample distribution. The Cronbach a value for the GLHC was .92 for this study sample (for R/S survey questions, see Supporting Table 1 ).
Health Care Access, Utilization, and Communication
A scale measuring quality of patient-provider communication (PPC) (5 items; possible score range, 5-25) was administered using a 5-point Likert scale (always, almost always, sometimes, rarely, and never). 18 Scales measuring health habits of utilization (for women, mean of 9 items scored on a 4-point Likert scale; for men, mean of 8 items; for both, possible scores range from 1 to 4) and perceived access to care (10 items; possible scores range, 10-40) were administered using a 4-point Likert scale (strongly disagree, disagree, agree, and strongly agree). 19, 20 A summed composite score was taken for the PPC and access to care scales. For the health habits of utilization scale, we took the item mean score as the number of items that differed between women and men (for scales, see Supporting Table 1 ).
Screening knowledge and history
Types of prior screening for colon cancer were reported in patient surveys and were categorized as any or none for analysis. Patients also had a chance during interviews to name or describe colon cancer screening tests without probing on the part of the interviewer. A variable for tests correctly named or described was categorized as none, 1, and 2.
Depression
The frequency of depression was assessed by patient report at the time of interview with a single-item, 3-point Likert scale (hardly ever or never, some of the time, and often). Responses were summed and dichotomized into hardly ever/never versus sometimes/often.
Analysis
We examined how the prevalence of late stage at diagnosis varied by patient characteristics using the variable categorizations outlined above. We also estimated corresponding chi-square or t tests and their associated P values, as appropriate. Variables with P values < .10 were retained in the initial logistic regression model. In addition, the study team agreed a priori to include age, recruitment facility, and prior colon cancer screening history in all models based on study hypotheses. Therefore, all subsequent models included the following covariates: age, depression, screening knowledge, screening history, and recruitment facility (9 hospitals, dummy coded). Because of oversampling of black participants and a high nonresponse rate, weights were created to match the full distribution of eligible patients identified by study staff at the 9 participating facilities on race, age, recruitment facility, and sex (these were the only variables collected on both responders and nonresponders). The sample was then weighted similarly for age (in decades), then for recruitment facility, then for sex, and finally for race again. This was done iteratively until the final distribution of the weighted sample was within 1% of the distribution of the full sample of eligible patients (5 rounds of weighting). Given the high correlations ranging among the measures of religiosity (GHLC tertile with RPS-D tertile, .63; GLHC tertile with RPSC tertile, .56, and RPS-D and RPS-C tertile, .73), the inclusion of multiple religiosity measures in the same model substantially increased the standard error for the estimates of their associations with late stage at colon cancer diagnosis. Therefore, we estimated 4 multivariable logistic regression models that included 1) the GLHC score; 2) the RPS-D score; 3) the RPS-C score; and 4) the GLHC, RPS-D, and RPS-C scores. We performed these aforementioned analyses first for all participants, and then for participants at aged 50 years separately as part of a sensitivity analysis, because the recommendation is to begin colon cancer screening at age 50 years in the general population. For all analyses, we used pairwise deletion for bivariate associations and list wise deletion for multivariate regression analysis to handle missing data. Sample sizes are provided for all regression models. Across all regression models, the largest missing proportion was 8.25% when we use list wise deletion.
RESULTS
Population Characteristics
The final analytic sample with complete staging information included 389 patients (see Table 1 ). Approximately 60% were diagnosed at a late disease stage Original Article (n 5 233), and 40% were diagnosed at an early disease stage (n 5 156). Stage was not available for 18 patients (4%). The overall sample was nearly equally divided by race (51% black and 49% white) and sex (51% women). Most of the sample (62%) had greater than a high school education, and one-third had annual incomes <$20,000. Nearly one-half of patients were recruited from private academic hospitals, and the remaining onehalf were equally divided between public and private nonacademic hospitals. Patients with late-stage disease had lower colon cancer screening knowledge (P 5 .008) and higher rates of depression (P 5 .01). There was no statistically significant association between race and late stage of presentation (P 5 .21). 
R/S and Late Stage of Presentation
Patients who presented with late-stage versus early stage disease had higher mean scores on the GLHC scale (mean, 18.98 vs 16.15, respectively; P 5 .001) ( Table 2 ). These patients also had higher mean scores on the RPS-D subscale, although the difference was only marginally statistically significant (mean, 18.25 vs 16.74, respectively; P 5 .11). RPS-C scores were higher among patients diagnosed with latestage disease, but this result was not statistically significant (mean, 20.73 vs 19.90, respectively; P 5 .36). Approximately 38% of those diagnosed with late-stage disease were in the highest tertile of GLHC scores versus 23% of those diagnosed with early stage disease (P < .01).
Multivariate Model
First, we completed our analyses with participants from all age groups, ranging from age <50 to >70 years (Table  3 , top). Then, for sensitivity analysis, we repeated the same analyses including only participants who were aged 50 years (Table 3 , bottom). The top section of Table 3 indicates that, in the 3 multivariate models that included age, hospital, prior screening, depression, cancer knowledge, and the religiosity measures separately, the GLHC score was the only religiosity measure significantly associated with late disease stage at colon cancer diagnosis. More specifically, patients who had scores in the highest tertile of GLHC were more likely have advanced-stage disease at presentation (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.00-3.19; P 5 .05) compared with those who had scores in the lowest tertile. In the fourth model, which included all 3 religiosity measures, the association of the GLHC score with late disease stage remained statistically significant (OR, 2.14; 95% CI, 1.00-4.59; P 5 .05). Age had a significant negative association with late stage at colon cancer diagnosis (P 5 .03 to .06) in all models. More specifically, patients between ages 60 and 69 years or aged >70 years were less likely to have late-stage disease at colon cancer diagnosis compared with the youngest group (aged <50 years).
Data from bottom section of Table 3 , in which the analysis was restricted to a screening-eligible population aged 50 years, reveal the same patterns, except that the strength of association between the GLHC score and late disease stage at diagnosis becomes stronger both in model 1 (OR, 2.14; 95% CI, 1.13-4.04; P 5 .02) and in model 4 (OR, 2.69; 95% CI, 1.21-5.98; P 5 .02).
Race and Religiosity/Spirituality
Black respondents had significantly higher mean scores on the GLHC scale (mean score, 22 vs 13 on a scale from 6 to 30), the RPS-D subscale (mean score, 23 vs 12), and the RPS-C subscale (mean score, 25 vs 15) compared with white respondents (see Table 4 ). All of these race-based differences were statistically significant (P < .001). Approximately 50% of blacks were in the highest tertile of each of the religiosity/spirituality measures compared with only 10% of whites. However, although black respondents had higher GLHC scores and GLHC scores were associated with advanced disease stage at diagnosis, there was no interaction between race, GLHC score, and disease stage at colon cancer presentation (P 5 .78; data not shown).
DISCUSSION
The current study was designed around 2 central hypotheses: 1) deferring to God's control for religious problem solving and high levels of a God locus of control would be associated with advanced-stage disease at presentation, and 2) this association would be stronger for blacks compared with whites. Only our first hypothesis was partially supported, in that high levels of God locus of control ("God is in control of my health," and "Whatever happens to my health is God's will") were associated with late-stage disease at presentation in both univariate and multivariate modeling. Deferring to God ("In carrying out solutions to my problems, I wait for God to take control and know somehow He'll work it out") was more frequent among those with late-stage disease, but the difference was only marginally significant. Although blacks had much higher scores on GLHC and deferring to God, there was no indication that the correlation to disease stage differed by race. That is, both black and white respondents who had high GLHC scores were statistically more likely to present with late-stage disease.
The correlation between religious/spiritual beliefs and health is complicated. Measures for religiosity and spirituality can operate in opposite directions, may be mediated by unknown factors, and can interact differently across race and culture. One set of popular measures center around religious activities, such as religious affiliation and attendance at worship services. Several studies have reported lower mortality rates and lower risk behaviors among those who more frequently attend religious services. 8, 21, 22 The social support associated with involvement in a religious community may explain some of these associations.
In contrast, we focused on 2 different dimensions of religiosity in the current study: religious beliefs associated with health and religious problem solving. Our focus on religious beliefs about health examined the degree to which patients with cancer place God at the center of their health locus of control ("God is in control of my health"). Placing God at the center of the health locus of control has been described as a type of externalizing religious belief. 10 Religious coping, or problem solving, is a second dimension of religion. It refers to religiously oriented or religiously informed actions that individuals take in the face of problems or stressors. Kenneth Pargament (the leading theorist on religious coping) and colleagues describe 2 dimensions of religious problem solving: deferring ("I do not think about different solutions to my problems, because God provides them for me") and collaborative ("Together, God and I put my plans into action").
14 Similar to the findings in our study, a casecontrol study (540 cases, 414 controls) of women in eastern North Carolina by Lannin and colleagues 11 indicated that women who held the externalizing religious belief, "If a person prays about cancer, God will heal it without medical treatment," were nearly 2 times as likely to present with advanced breast cancer.
In part of the Landmark Spirituality and Health Survey, a nationally representative sample of 2948 community-dwelling adults, the investigators observed a negative correlation between what they termed, divine deferral and physical health. 10 A study among 276 members of African American churches in the Nashville area using subscales that measured religious health fatalism also reported negative associations with physical activity, health promotion, and health screenings. 23 We should treat the findings from these prior studies with caution because of their methodological limitations, including small samples or samples from 1 racial/ethnic group. Also, several studies were based on single-item measures of religious belief 11 or measures of religious belief that have not been widely validated. 23, 24 Finally, many of the prior studies used limited outcomes, such as the intention to receive screening or to engage in physical activity, rather than actual, observed behaviors. The strength of the current study is that it included a large sample of black and white respondents, multiple well validated measures of religious beliefs, and outcomes verified from medical records. This lends support to the strength of our finding of an association between GLHC scores and late disease stage at presentation.
Surprisingly, although the GLHC scale was associated with stage at cancer diagnosis, contrary to our hypothesis, deferring religious problem solving was not. One possibility is that this was a matter of statistical power, because, there was a magnitude but not statistical difference in deferring scores between late and early stage cancers. Another possibility is that locus of control and deferring to God measure overlapping but distinct dimensions of externalizing religious beliefs that are not captured by the measures used in our study. This will require further investigation but emphasizes the importance of including multiple measures of R/S, as was done in this study.
Regarding the question of race, religiosity, and cancer outcomes, we did confirm the different rates of religious beliefs and coping in this large black and white sample. However, we also observed that, once these beliefs are held, they act similarly for both blacks and whites. Because there was no difference in disease stage at presentation by race in this cohort, we were not able to test whether differences in religious beliefs mediated differences in stage. When studying racial/ethnic-based health disparities, it is important to understand the role spirituality plays in the black experience, because it is historically, socially, and culturally distinct from that in the white American experience. This is a phenomenon substantiated in a large body of data collected from community and clinical samples, 25, 26 including cancer survivors. 4, [27] [28] [29] Our own previous research 15 demonstrated that black patients with cancer reported higher levels of religiosity (measured by the GLHC) compared with white patients with cancer, and this difference persisted after adjustments for income and education levels.
Implications for Future Research
An important implication of this study is that the health care system needs to better understand and acknowledge the religious beliefs and coping styles of the patients it serves. For too long, the role of religion in medicine has often been relegated to the care of the dying patient. In the current study, we have an example in which religious beliefs may be influencing decision making very early in the health care continuum. Further research, including surveys and in-depth interviews, is needed to confirm these findings and to clarify which factors may have contributed to them. For example, do high levels of God locus of health control affect the awareness of symptoms or only decisions about when to seek medical attention? 30 There is also evidence that involving the health care team in the religious and spiritual needs of patients with cancer can impact outcomes. A study led by Balboni and colleagues emphasized the importance of spiritual support being provided by the medical team to those patients with cancer who have strong religious support from their faith communities and observed that those who received spiritual support only from their religious community were significantly more likely to receive aggressive end-oflife care, including death in intensive care units. However, the religious patients who also received spiritual support from the medical team actually were more likely to enroll in hospice and less likely to receive aggressive end-of-life care. 31 
Study Limitations
The main limitation of the current study is that of potential selection bias. This was not a population-based, random sample but, rather, a study of patients who were identified at 9 Chicago area hospitals and agreed to undergo a 90-minute interview. Although the 52% participation rate is respectable for a study of this type, we cannot exclude the possibility that those who did not agree to participate and those who presented at other area hospitals might be fundamentally different from the studied population. For example, it is possible that those with high God locus of control and/or distrust of the health care system would be both more likely to present with advancedstage disease and less likely to agree to participate in a study like ours. If so, then our findings would be biased, but the bias would be toward the null hypothesis.
The cross-sectional design of the study is also a limitation and leaves open a question about the direction of the association between advanced stage of illness and God locus of control; that is, are those with God locus of control more likely to present with advanced disease, or are those with advanced disease more likely to develop high God locus of control? The limited available evidence suggests a stable trajectory of religious beliefs in patients with serious illness, 32 but additional longitudinal studies are needed to address this question. In addition, with regard to religious beliefs, it could be hypothesized that those who choose not to engage the health care system may hold even stronger beliefs in the role of God alone in their health; therefore, this study may be underestimating the impact of externalizing religious beliefs, but we do not have data to support that possibility. Also, we were not able to demonstrate how religious beliefs may lead to advanced stage of presentation, because none of the potential hypothesized mediators, such as health care access and utilization or PPC, were associated with advanced stage at presentation in this study.
Finally, it could be argued that we should have focused our analysis only on a screening-eligible population (those age 50 years), because this is the group that should be getting screened almost without exception. We opted from the inception of the study to include all patients ages 30 to 79 years to capture those who may have had symptoms (blood in the stool, weight loss) but who did not receive appropriate diagnostic testing in a timely fashion. We did conduct a sensitivity analysis by restricting our data to the group ages 50 to 79 years; and, although the effect size changed, the significance, direction of the change, and interpretation of the data did not. The larger effect size for the population ages 50 to 79 years is not surprising, because the decision to delay screening or ignore symptoms in a population with a higher incidence of precancerous and cancerous lesions would be expected to have a more detrimental impact on stage of cancer at diagnosis.
In summary, in this cohort of black and white patients with cancer from the metropolitan Chicago area, strong religious beliefs, as captured by the GHLC scale, were associated with advanced stage of colon cancer at presentation. Future work should focus on both investigating the paths by which this association occurs and developing interventions to better integrate the medical and religious worlds within the health care system, especially for patients whose lives and actions are guided by the role they believe God plays in their illness. 
